Global Fetal Bovine Serum Market: Snapshot

The global market for fetal bovine serum is gaining momentum on the back of rising demand for fetal bovine serum for research studies. Fetal bovine serum is important for ground-breaking research in drug development and finds wide applications in cell-based pharmaceutical research. Fetal bovine serum is a key feedstock in pharmaceutical, diagnostics, biotechnology, diagnostic, and veterinary industries. Fetal bovine serum, a by-product of the beef industry is a crucial raw material for animal health, biotechnology, pharmaceutical research, and diagnostic as well as other research areas.

However, in the past few years, the fetal bovine serum industry is witnessing product shortage due to climatic uncertainties along with increased beef and dairy demand that has led to a drastic drop in cattle herd population lowest in 60 years.

As per projections of a market study by Transparency Market Research (TMR), the global fetal bovine serum market is anticipated to clock a healthy 8.0% CAGR for the forecast period between 2017 and 2025, for the market to be worth US$1,396.1 mn by the end of 2025 from its value of US$695.3 mn in 2016.

Cell Culture Media Application Segment to Continue to Remain in Lead

The report divides the global fetal bovine serum market based on a few parameters, viz. application, end-user, and region. Based on application type, the fetal bovine serum market is segmented into drug discovery, in vitro fertilization, cell culture media, diagnostics, human and animal vaccine production, and others. Vis-à-vis value and volume, the cell culture media segment led the market in 2016 and is anticipated to maintain its leading position over the forecast period owing to increasing cell culture applications of fetal bovine serum.

Based on end-user type, the fetal serum bovine market is segregated into research and academic institutes and industry (pharma, biotech, etc.). The industry segment held the leading market share of the fetal bovine market in 2016 in terms of both value and volume. This is mainly because of increasing demand for fetal bovine serum from pharmaceutical and biotechnology industry.

Emergence of Contract Research Organizations to Make Asia Pacific Prominent Market

The global fetal bovine serum market has been segmented into five key regions, namely North America, Asia Pacific, Latin America, Europe, and the Middle East and Africa. Of them, in 2016, North America led the fetal bovine serum market vis-à-vis value due to the high consumption and high pricing of fetal bovine serum in the region. Europe is currently a significant market for fetal bovine serum; going forward, the region is anticipated to display declined growth because of religious sentiments and ethical issues pertaining to animal-derived products. Low pricing of fetal bovine serum also accounts for a low market share of Europe.

The Asia Pacific market for fetal serum bovine is anticipated to witness notable growth rate over the forecast period. The rapid emergence of contract research organizations in the region, especially in India and China is a key factor behind the growth of this regional market. Infrastructural development along with the presence of a large educated population pool are key factors behind the emergence of these countries as favored destinations for research pursuits. Large research organizations in the West are increasingly outsourcing research activities to these countries for relatively low cost without compromising on the quality of research.

Prominent names in the fetal bovine serum market include Merck KGaA, Atlanta Biologicals Inc., Tissue Culture Biologicals, HiMedia Laboratories, Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., Rocky Mountain Biologicals , GE Healthcare, and PAN-Biotech.

Global Fetal Bovine Serum Market: Overview

The report on the fetal bovine serum market analyzes the current and future scenario of the global market. Increased demand for fetal bovine serum in the growing pharmaceutical & biotechnology industries, increase in academic research activities worldwide, and rising consumption of fetal bovine serum in emerging markets are the major drivers of the global fetal bovine serum market.

The fetal bovine serum market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global fetal bovine serum market with respect to the segments based on application type, end-user type and geography. A detailed qualitative analysis of drivers and restraints of the market and its opportunities has been provided in the market overview section. In addition, the section comprises Porter’s five forces analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global fetal bovine serum market.

Global Fetal Bovine Serum Market: Market Segmentation

Based on application type, the fetal bovine serum market is segmented as drug discovery, cell culture media, in vitro fertilization, human and animal vaccine production, diagnostics, and others. The market size and forecast, in terms of value & volume, for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on end-user type, fetal bovine serum market is segmented into research & academic institutes, and industry {pharma, biotech, etc.). The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global fetal bovine serum market has been categorized into five major regions and the key countries in the respective regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, Israel and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The country wise market size and analysis for each segment in terms of value & volume has been provided in the report. The research study also covers o in these the competitive regions.

Global Fetal Bovine Serum Market: Competitive Landscape

The report also profiles major players in the global fetal bovine serum market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include – Merck KGaA, Thermo Fisher Scientific, Inc., GE Healthcare, TCS Biosciences Ltd., HiMedia Laboratories, Atlanta Biologicals, Inc., PAN-Biotech, Rocky Mountain Biologicals, Bovogen Biologicals Pty Ltd, Tissue Culture Biologicals., and others.

The global fetal bovine serum market is segmented as given below:

Global Fetal Bovine Serum Market, by Application

  • Drug Discovery
  • Cell Culture Media
  • In vitro Fertilization
  • Human and Animal Vaccine Production
  • Diagnostics
  • Others

Global Fetal Bovine Serum Market, by End-user

  • Research & Academic Institutes
  • Industry (pharma, biotech, etc.)

Global Fetal Bovine Serum Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa
.